HSV-1 and HSV-2 Detection via Multiplex Real-Time PCR
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing Herpes simplex virus 1 and 2 infections are time-consuming, labor-intensive, and lack sensitivity and specificity, particularly in distinguishing between the two types simultaneously.
Innovation Solution
A real-time PCR assay that uses specific primers and probes targeting HSV-1 and HSV-2 genes, such as viral DNA polymerase B, thymidine kinase C, and glycoprotein B, to detect and differentiate both viruses in a single reaction tube, enhancing sensitivity and specificity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional cell culture methods are used for HSV diagnosis, then the diagnosis can be performed, but the process is time-consuming and labor-intensive
Solution Approach 1:
The patent replaces traditional mechanical cell culture methods with a molecular biology-based PCR detection system. The invention uses specific primers and probes to directly detect viral DNA in clinical specimens, eliminating the need for time-consuming cell culture procedures while maintaining diagnostic accuracy and enabling rapid results within hours.
Solution Approach 2:
The patent changes the detection parameter from observing cellular effects of viral infection to directly detecting viral genetic material. By using PCR amplification and specific probes, the method transforms the detection approach to measure viral DNA presence and quantity directly, significantly reducing the time required for diagnosis compared to cell culture methods.
2Reliability
If traditional serologic diagnosis methods are used, then the diagnosis can be performed, but the sensitivity and specificity are insufficient
Solution Approach 1:
The patent applies local quality by designing type-specific primers and probes that target unique regions of HSV-1 and HSV-2 genomes. The primers and probes are specifically engineered to recognize sequence differences between the two viral types, enabling precise differentiation and eliminating cross-reactivity issues that limit the sensitivity and specificity of traditional serologic methods.
Solution Approach 2:
The patent replaces serologic methods that detect antibodies with a molecular detection system that directly identifies viral DNA. This substitution eliminates the indirect nature of serologic diagnosis and provides direct, sensitive, and specific detection of active viral infection, significantly improving measurement precision and reliability.
3Productivity
If separate tests are performed for HSV-1 and HSV-2, then each virus can be detected, but the process requires multiple test tubes and is less efficient
Solution Approach 1:
The patent merges the detection of HSV-1 and HSV-2 into a single PCR reaction tube by using four distinct probes (two for HSV-1, two for HSV-2) that can be simultaneously detected. This combining approach allows parallel detection of both viral types in one test, improving efficiency and reducing the number of separate tests required while maintaining the ability to differentiate between virus types.
Solution Approach 2:
The patent creates a universal detection system that can identify both HSV-1 and HSV-2 in a single assay. The primer set is designed to amplify conserved regions present in both viral types, while type-specific probes differentiate between them, providing multi-functional capability in one test tube and eliminating the need for separate testing procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and accurate detection of HSV-1 and HSV-2 infections with improved sensitivity and specificity, allowing for simultaneous detection and differentiation in a single test, reducing the risk of false negatives and false positives.
Implementation Method 1
performing an amplifying step including contacting the sample with a plurality of sets of HSV-1 and HSV-2 primers to produce one or more amplification products
Implementation Method 2
real-time polymerase chain reaction in a single test tube
Implementation Method 3
contacting the one or more amplification products with a plurality of detectable HSV-1 and HSV-2 probes; and detecting the presence or absence of the one or more amplification products
Implementation Method 4
multiplex detection of HSV-1 and/or HSV-2 by real-time polymerase chain reaction
Data Source
AI summary
Methods for the rapid detection of the presence or absence of Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) in a biological or non-biological sample are described. The methods can include performing an amplifying step, a hybridizing step, and a detecting step. Furthermore, primers, probes targeting the genes for HSV-1 viral DNA polymerase B (HSV-1 Pol) and HSV-1 thymidine kinase C (HSV-1 TK), and also target the genes for HSV-2 thymidine kinase C (HSV-2 TK) and HSV-2 glycoprotein B (HSV-2 gB), along with kits are provided that are designed for the detection of HSV-1 and/or HSV-2.